Fig. 6

Identification of myeloid cells from BALC samples of TB patients. FSC and SSC characteristics were selected to define all BALC. All subsequent analyses were performed on cells selected in the BALC gate. a Gating strategy used to define CD11b + CD33+ innate cells from BALC with low autofluorescence signal. b Gating strategy selected to define CD11b + CD33+ innate cells from BALC presenting with extensive autofluorescence. c Gating strategy identifying CD11b + CD33+ innate cells from the same BALC indicated in (b), post quenching treatment